Kamla Kant

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Staphylococcus Aureus

Respiratory Syndrome Coronavirus

Angiotensin Converting Enzyme

Antimicrobial Resistance

Top Venues

Journal of medical virology

JMIR bioinformatics and biotechnology

International reviews of immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Ashutosh Kumar, Adil Asghar, Himanshu Narayan Singh, Muneeb A Faiq, Sujeet Kumar, Ravi Kant Narayan, Gopichand Kumar, Prakhar Dwivedi, Chetan Sahni, Rakesh Kumar Jha, Maheswari Kulandhasamy, Pranav Prasoon, Kishore Sesham, Kamla Kant, Sada N Pandey
SARS-CoV-2 Omicron Variant Genomic Sequences and Their Epidemiological Correlates Regarding the End of the Pandemic: In Silico Analysis. JMIR bioinformatics and biotechnology 4 (2023)
Ashutosh Kumar, Adil Asghar, Himanshu Narayan Singh, Muneeb A Faiq, Sujeet Kumar, Ravi Kant Narayan, Gopichand Kumar, Prakhar Dwivedi, Chetan Sahni, Rakesh Kumar Jha, Maheswari Kulandhasamy, Pranav Prasoon, Kishore Sesham, Kamla Kant, Sada N Pandey
SARS-CoV-2 Omicron Variant Genomic Sequences and Their Epidemiological Correlates Regarding the End of the Pandemic: In Silico Analysis. JMIR bioinformatics and biotechnology 4 (2023)
Ashutosh Kumar, Rakesh Parashar, Sujeet Kumar, Muneeb A Faiq, Chiman Kumari, Maheswari Kulandhasamy, Ravi Kant Narayan, Rakesh Kumar Jha, Himanshu Narayan Singh, Pranav Prasoon, Sada N Pandey, Kamla Kant
Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19. Journal of medical virology (2021)
Ashutosh Kumar, Pranav Prasoon, Chiman Kumari, Vikas Pareek, Muneeb A Faiq, Ravi Kant Narayan, Maheswari Kulandhasamy, Kamla Kant
SARS-CoV-2-specific virulence factors in COVID-19. Journal of medical virology 93 (3) (2020)
Ashutosh Kumar, Pranav Prasoon, Prakash S Sekhawat, Vikas Pareek, Muneeb A Faiq, Chiman Kumari, Ravi Kant Narayan, Maheswari Kulandhasamy, Kamla Kant
Pathogenesis guided therapeutic management of COVID-19: an immunological perspective. International reviews of immunology 40 (1-2) (2020)